EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Harnessing γδ T Cells against Human Gynecologic Cancers

Jose R Conejo-Garcia iD, Carmen M Anadon, Luis U Lopez-Bailon, Ricardo A Chaurio iD

Life · 29.02.2024 · 14 (3) · 325

DOI: 10.3390/life14030325 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Life, online erschienen am 29.02.2024. Verfasst von Jose R Conejo-Garcia und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Immunobiology, Duke School of Medicine, Durham, NC 27710, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Cancer Research Institute, The National Institute of Health/National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immuno-oncology has traditionally focused on conventional MHC-restricted αβ T cells. Yet, unconventional γδ T cells, which kill tumor cells in an MHC-unrestricted manner, display characteristics of effector activity and stemness without exhaustion and are nearly universally observed in human gynecologic malignancies, correlating with improved outcomes. These cells do not have a clear counterpart in mice but are also found in the healthy female reproductive tract. Interventions that modulate their in vivo activity, or cellular therapies utilizing γδ T cells as an allogeneic, “off-the-shelf” platform (e.g., for chimeric antigen receptor expression) hold significant potential against challenging tumors like ovarian cancer, which has been stubbornly resistant to the immune checkpoint inhibitors that change the landscape of other human tumors. Here, we discuss recent discoveries on the specific populations of γδ T cells that infiltrate human gynecologic cancers, their anti-tumor activity, and the prospect of redirecting their effector function against tumor cells to develop a new generation of immunotherapies that extends beyond the traditional αβ T cell-centric view of the field.

Schlagwörter

Stichwörter der Autor:innen

T cellbutyrophilincancer immunotherapychimeric antigen receptortumor immunologyγδ T cell

Autor:innen und Institutionen

  • Department of Integrative Immunobiology, Duke School of Medicine, Durham, NC 27710, USA.
  • Duke Cancer Institute, Duke School of Medicine, 2128 MSRBIII, 3 Genome Ct, Durham, NC 27707, USA.

ORCID-Profile: Jose R Conejo-Garcia, Ricardo A Chaurio

Förderung

  • NCI NIH HHS
  • Cancer Research Institute
  • The National Institute of Health/National Cancer Institute

Zitieren

APA

Conejo-Garcia, J. R., Anadon, C. M., Lopez-Bailon, L. U., & Chaurio, R. A. (2024). Harnessing γδ T Cells against Human Gynecologic Cancers. Life, 14(3), 325. https://doi.org/10.3390/life14030325

Vancouver

Conejo-Garcia JR, Anadon CM, Lopez-Bailon LU, Chaurio RA. Harnessing γδ T Cells against Human Gynecologic Cancers. Life. 2024;14(3):325. doi:10.3390/life14030325

BibTeX
@article{ConejoGarcia2024,
  author = {Conejo-Garcia, Jose R and Anadon, Carmen M and Lopez-Bailon, Luis U and Chaurio, Ricardo A},
  title = {Harnessing γδ T Cells against Human Gynecologic Cancers},
  journal = {Life},
  year = {2024},
  volume = {14},
  number = {3},
  pages = {325},
  doi = {10.3390/life14030325}
}
Kostenlos starten →